Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
A key barrier to the development of vaccines that induce broadly neutralizing antibodies (bnAbs) against human immunodeficiency virus (HIV) and other viruses of high antigenic diversity is the design of priming immunogens that induce rare bnAb-precursor B cells. The high neutralization breadth of the HIV bnAb 10E8 makes elicitation of 10E8-class bnAbs desirable; however, the recessed epitope within gp41 makes envelope trimers poor priming immunogens and requires that 10E8-class bnAbs possess a long heavy chain complementarity determining region 3 (HCDR3) with a specific binding motif. We developed germline-targeting epitope scaffolds with affinity for 10E8-class precursors and engineered nanoparticles for multivalent display. Scaffolds exhibited epitope structural mimicry and bound bnAb-precursor human naive B cells in ex vivo screens, protein nanoparticles induced bnAb-precursor responses in stringent mouse models and rhesus macaques, and mRNA-encoded nanoparticles triggered similar responses in mice. Thus, germline-targeting epitope scaffold nanoparticles can elicit rare bnAb-precursor B cells with predefined binding specificities and HCDR3 features.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119
MolProbity: More and better reference data for improved all‐atom structure validation
Williams, C. J., Headd, J. J., Moriarty, N. W., Prisant, M. G., Videau, L. L., Deis, L. N., Verma, V., Keedy, D. A., Hintze, B. J., Chen, V. B., et al. (2018) · Protein Science · doi:10.1002/pro.3330 · Cited by 4,599
Leaver-Fay (2011) · doi:10.1016/b978-0-12-381270-4.00019-6 · Cited by 1,904 · cited 1×
“Computational modeling using the Rosetta Software suite 52,53 resulted in 10E8-GT2 that resolved this clash and bound weakly (1.5 µM) to 10E8-iGL1.”
MethodInfluentialEvaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
Corbett, K. S., Flynn, B., Foulds, K. E., Francica, J. R., Boyoglu-Barnum, S., Werner, A. P., Flach, B., O’Connell, S., Bock, K. W., Minai, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2024671 · Cited by 1,066 · cited 1×
“Mice were injected with 10 µg (50 µl total volume) of Moderna mRNA-LNPs 80,81 encoding 10E8-GT12 24mer intramuscularly under anesthesia (5% isoflurane induction) in the left quadriceps muscle.”
MethodSelf-citationRational HIV Immunogen Design to Target Specific Germline B Cell Receptors
Jardine, J., Julien, J.-P., Menis, S., Ota, T., Kalyuzhniy, O., McGuire, A., Sok, D., Huang, P.-S., MacPherson, S., Jones, M., et al. (2013) · Science · doi:10.1126/science.1234150 · Cited by 770 · cited 3×
“To use known bnAbs as guides for the design of vaccines that elicit similar responses, strategies to induce bnAbs with predefined genetic properties and binding specificities are needed 5–7 .”
BackgroundMethodSelf-citationProof of principle for epitope-focused vaccine design
Correia, B. E., Bates, J. T., Loomis, R. J., Baneyx, G., Carrico, C., Jardine, J. G., Rupert, P., Correnti, C., Kalyuzhniy, O., Vittal, V., et al. (2014) · Nature · doi:10.1038/nature12966 · Cited by 555
Self-citationCommonality despite exceptional diversity in the baseline human antibody repertoire
Briney, B., Inderbitzin, A., Joyce, C., & Burton, D. R. (2019) · Nature · doi:10.1038/s41586-019-0879-y · Cited by 544
Self-citationCirelli, K. M., Carnathan, D. G., Nogal, B., Martin, J. T., Rodriguez, O. L., Upadhyay, A. A., Enemuo, C. A., Gebru, E. H., Choe, Y., Viviano, F., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.012 · Cited by 433
Self-citationOlsen, T. H., Boyles, F., & Deane, C. M. (2022) · Protein Science · doi:10.1002/pro.4205 · Cited by 319
McGuire, A. T., Hoot, S., Dreyer, A. M., Lippy, A., Stuart, A., Cohen, K. W., Jardine, J., Menis, S., Scheid, J. F., West, A. P., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122824 · Cited by 309
Self-citation
Cited by
Broadly inhibitory antibodies to severe malaria virulence proteins
Reyes, R. A., Raghavan, S. S. R., Hurlburt, N. K., Introini, V., Bol, S., Kana, I. H., Jensen, R. W., Martinez-Scholze, E., Gestal-Mato, M., López-Gutiérrez, B., et al. (2024) · Nature · doi:10.1038/s41586-024-08220-3 · Cited by 35
Self-citation(2026) · doi:10.1073/pnas.2532810123 · Cited by 8
Research progress on HIV-1 structural proteins and antiviral therapies
Wang, H., Yuan, J., & Wang, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1805597 · Cited by 2
“The membrane-proximal external region (MPER) of gp41 is a conserved epitope recognized by broadly neutralizing antibodies such as 2F5, 4E10, Z13e1, 10E8 and DH511 (68).”
Metadata
- Authors
- Schiffner, T., Phung, I., Ray, R., Irimia, A., Tian, M., Swanson, O., Lee, J. H., Lee, C.-C. D., Marina-Zárate, E., Cho, S. Y., Huang, J., Ozorowski, G., Skog, P. D., Serra, A. M., Rantalainen, K., Allen, J. D., Baboo, S., Rodriguez, O. L., Himansu, S., Zhou, J., Hurtado, J., Flynn, C. T., McKenney, K., Havenar-Daughton, C., Saha, S., Shields, K., Schultze, S., Smith, M. L., Liang, C.-H., Toy, L., Pecetta, S., Lin, Y.-C., Willis, J. R., Sesterhenn, F., Kulp, D. W., Hu, X., Cottrell, C. A., Zhou, X., Ruiz, J., Wang, X., Nair, U., Kirsch, K. H., Cheng, H.-L., Davis, J., Kalyuzhniy, O., Liguori, A., Diedrich, J. K., Ngo, J. T., Lewis, V., Phelps, N., Tingle, R. D., Spencer, S., Georgeson, E., Adachi, Y., Kubitz, M., Eskandarzadeh, S., Elsliger, M. A., Amara, R. R., Landais, E., Briney, B., Burton, D. R., Carnathan, D. G., Silvestri, G., Watson, C. T., Yates, J. R., Paulson, J. C., Crispin, M., Grigoryan, G., Ward, A. B., Sok, D., Alt, F. W., Wilson, I. A., Batista, F. D., Crotty, S., & Schief, W. R.
- Venue
- Nature Immunology
- Published
- 2024-05-30
- Volume
- 25
- Issue
- 6
- Pages
- 1073-1082
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W4399180501
- Cited by
- 53
- References
- 12
- FWCI
- 10.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vaccination induces broadly neutralizing antibody precursors to HIV gp41. https://app.cochat.ai/papers/10.1038/s41590-024-01833-w
- The paper
- Schiffner, T., Phung, I., Ray, R., Irimia, A., Tian, M., Swanson, O., Lee, J. H., Lee, C.-C. D., Marina-Zárate, E., Cho, S. Y., Huang, J., Ozorowski, G., Skog, P. D., Serra, A. M., Rantalainen, K., Allen, J. D., Baboo, S., Rodriguez, O. L., Himansu, S., . . . Schief, W. R. (2024). Vaccination induces broadly neutralizing antibody precursors to HIV gp41. Nature Immunology. https://doi.org/10.1038/s41590-024-01833-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.